Chiral Chromatography for Lacosamide Optical Purity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing Lacosamide, an anticonvulsive drug, are inefficient due to high costs, environmental concerns, and productivity issues related to the use of expensive reagents like methyl iodide and silver (I) oxide, which also lead to partial racemization and safety hazards during large-scale production.

Innovation Solution

A process involving chiral chromatographic separation using a polymeric chiral selector immobilized on a silica backbone, such as cellulose tris(3,5-dichlorophenylcarbamate), to achieve optically enriched or substantially optically pure (R)-2-acetamido-N-benzyl-3-methoxypropion-amide, avoiding iterative purification steps and recycling of the undesired enantiomer to enhance yield and productivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If methyl iodide and silver (I) oxide are used as O-methylation agents, then O-methylation can be achieved, but the process becomes expensive and leads to partial racemization

Engineering Contradiction:
Improveoptical purityVSAvoidprocess cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent replaces expensive reagents (methyl iodide and silver oxide) with a cheaper alternative O-methylation agent, reducing material costs while maintaining product quality. The use of more affordable reagents makes the process economically viable for industrial production.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent modifies the reaction conditions and reagent selection to prevent racemization. By changing the O-methylation methodology and optimizing reaction parameters, the process maintains high optical purity without requiring expensive chiral resolving agents or conditions.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If methyl iodide and silver (I) oxide are used as O-methylation agents, then O-methylation can be achieved, but productivity decreases due to partial racemization

Engineering Contradiction:
Improveoptical purityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent employs a cost-effective O-methylation agent that does not cause racemization, eliminating the need for additional purification steps to remove racemized products. This streamlined process increases production efficiency while maintaining optical purity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent implements a continuous production process where the O-methylation step directly yields the desired product with high optical purity. By avoiding interruptions for racemization correction or re-purification, the process maintains continuous productive operation.

Inventive Principle:
Principle #20Continuity of useful action

3Manufacturing precision

If dimethylsulphate is used as O-methylation agent, then O-methylation can be achieved, but safety and environmental issues arise during large-scale production

Engineering Contradiction:
Improveoptical purityVSAvoidsafety and environmental risks
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent substitutes dimethyl sulphate, a hazardous reagent, with a safer and more environmentally friendly O-methylation agent. This replacement eliminates toxic byproducts and safety concerns associated with dimethyl sulphate handling, making the process suitable for large-scale industrial production.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent transforms a potentially harmful process into a safe one by selecting an environmentally benign O-methylation methodology. The chosen reagent system converts what would be a hazardous operation into a safe, green chemical transformation that maintains product quality.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

4Reliability

If N-protection/N-deprotection steps are included, then amine moiety can be protected, but cost and productivity are reduced

Engineering Contradiction:
Improvechemical stabilityVSAvoidproduction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent removes unnecessary N-protection and N-deprotection steps from the synthesis pathway. By designing a route where the amine moiety does not require protection, the process eliminates additional reaction and purification steps, thereby increasing overall productivity and reducing costs.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent implements a streamlined synthesis where the amine group remains active throughout the reaction sequence. This continuous utility of the amine functionality eliminates interruptions for protection and deprotection, maintaining continuous productive flow and reducing total process time.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly improves the cost-efficiency and productivity of Lacosamide production by achieving high optical purity without environmental hazards and safety risks, allowing for increased yield and reduced operational costs.

Implementation Method 1

chiral chromatographic separation using a polymeric chiral selector immobilized on a silica backbone

Methodology Applied
Scientific EffectChiral recognition:

Implementation Method 2

chiral chromatographic separation using a polymeric chiral selector immobilized on a silica backbone

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 3

chiral chromatographic separation using a polymeric chiral selector immobilized on a silica backbone, such as cellulose tris(3,5-dichlorophenylcarbamate)

Methodology Applied
Scientific EffectChromatography: Chromatography

Data Source

PatentUS8946476B2Process for the preparation of amino acid derivatives
Publication Date: 2015.02.03 UCB PHARMA GMBH
  • US8946476B2 patent drawing
  • US8946476B2 patent drawing
  • US8946476B2 patent drawing

AI summary

The present patent application relates to an alternative process for the preparation of amino derivatives. In particular, the present application relates to an improved process for the manufacture of Lacosamide (LCM), (R)-2-acetamido-N-benzyl-3-methoxypropion-amide, which is useful as an anticonvulsive drug. In a particular aspect, the present invention relates to a process of manufacture of optically enriched (R)-2-acetamido-N-benzyl-3-methoxypropion-amide (I) comprising resolution of 2-acetamido-N-benzyl-3-methoxypropion-amide (II).